Cairn Investment Group, Inc. Gilead Sciences, Inc. Transaction History

Cairn Investment Group, Inc.

$174 Million
Q1 2024

A detailed history of Cairn Investment Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cairn Investment Group, Inc. holds 24,273 shares of GILD stock, worth $1.62 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

24,273

Previous 24,473 0.82%

Holding current value

$1.62 Million

Previous $1.98 Million 10.34%

% of portfolio

1.02%

Previous 1.24%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	SELL	$71.58 - $87.29 $14,316 - $17,458	-200 Reduced 0.82%	24,273 $1.78 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $99,280 - $112,586	1,355 Added 5.86%	24,473 $1.98 Million
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $257,680 - $281,134	3,485 Added 17.75%	23,118 $1.73 Million
Q2 2023 Aug 01, 2023	BUY	$76.01 - $86.7 $56,247 - $64,158	740 Added 3.92%	19,633 $1.51 Million
Q1 2023 Apr 24, 2023	BUY	$77.31 - $88.08 $1,546 - $1,761	20 Added 0.11%	18,893 $1.57 Million

Q4 2022 Jan 11, 2023	BUY	$62.32 - $89.47 $47,425 - $68,086	761 Added 4.2%	18,873 $1.62 Million
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $198,863 - $227,153	-3,340 Reduced 15.57%	18,112 $1.12 Million
Q2 2022 Jul 28, 2022	BUY	$57.72 - $65.01 $78,787 - $88,738	1,365 Added 6.8%	21,452 $1.33 Million
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $65,160 - $81,652	1,125 Added 5.93%	20,087 $1.54 Million
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $89,858 - $101,991	-1,385 Reduced 6.81%	18,962 $1.38 Million
Q3 2021 Nov 09, 2021	BUY	$67.69 - $73.03 $167,532 - $180,749	2,475 Added 13.85%	20,347 $1.42 Million
Q2 2021 Aug 12, 2021	BUY	$63.47 - $69.35 $27,609 - $30,167	435 Added 2.49%	17,872 $1.23 Million
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $95,700 - $109,193	-1,595 Reduced 8.38%	17,437 $1.13 Million
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $4,815 - $5,486	-85 Reduced 0.44%	19,032 $1.11 Million
Q3 2020 Nov 02, 2020	BUY	$62.1 - $78.08 $38,812 - $48,800	625 Added 3.38%	19,117 $1.21 Million
Q2 2020 Jul 21, 2020	SELL	$72.34 - $84.0 $30,021 - $34,860	-415 Reduced 2.19%	18,492 $1.42 Million
Q1 2020 Apr 24, 2020	BUY	$62.63 - $80.22 $652,291 - $835,491	10,415 Added 122.64%	18,907 $1.41 Million
Q4 2019 Jan 30, 2020	BUY	$61.62 - $67.78 $523,277 - $575,587	8,492 New	8,492 $551,000

Others Institutions Holding GILD

# of Institutions

1,885

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cairn Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cairn Investment Group, Inc. with notifications on news.

Account

Cairn Investment Group, Inc. Gilead Sciences, Inc. Transaction History